Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease

被引：0
|
作者：
Kanter, Julie
Walters, Mark C.
Hsieh, Matthew
Krishnamurti, Lakshmanan
Kwiatkowski, Janet L.
Kamble, Rammurti
von Kalle, Christof
Joseney-Antoine, Marcelyne
Pierciey, Francis J., Jr.
Shi, Weiliang
Asmal, Mohammed
Thompson, Alexis A.
Tisdale, John F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
527
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease
    Kanter, Julie
    Walters, Mark C.
    Hsieh, Matthew M.
    Krishnamurti, Lakshmanan
    Kwiatkowski, Janet
    Kamble, Rammurti T.
    von Kalle, Christof
    Kuypers, Frans A.
    Cavazzana, Marina
    Leboulch, Philippe
    Joseney-Antoine, Marcelyne
    Asmal, Mohammed
    Thompson, Alexis A.
    Tisdale, John F.
    BLOOD, 2016, 128 (22)
  • [2] LentiGlobin Gene Therapy in Patients with Sickle Cell Disease: Updated Interim Results from HGB-206
    Tisdale, John F.
    Kanter, Julie
    Mapara, Markus Y.
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Francis J.
    Shi, Weiliang
    Ribeil, Jean-Antoine
    Asmal, Mohammed
    Thompson, Alexis A.
    Walters, Mark C.
    MOLECULAR THERAPY, 2019, 27 (04) : 1 - 1
  • [3] Lentiglobin gene therapy in patients with sickle cell disease: Updated interim results from HGB-206
    Mapara, Markus Y.
    Tisdale, John F.
    Kanter, Julie
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Francis J., Jr.
    Shi, Weiliang
    Ribeil, Jean-Antoine
    Asmal, Mohammed
    Thompson, Alexis A.
    Walters, Mark
    BONE MARROW TRANSPLANTATION, 2019, 54 : 77 - 78
  • [4] LentiGlobin Gene Therapy in Patients with Sickle Cell Disease: Updated Interim Results from HGB-206
    Thompson, A. A.
    Tisdale, J. F.
    Kanter, J.
    Mapara, M. Y.
    Kwiatkowski, J. L.
    Krishnamurti, L.
    Schmidt, M.
    Miller, A.
    Pierciey, F. J.
    Shi, W.
    Ribeil, J. -A.
    Asmal, M.
    Walters, M. C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 22 - 23
  • [5] Lentiglobin Gene Therapy in Patients with Sickle Cell Disease: Updated Interim Results from Hgb-206
    Mapara, Markus Y.
    Tisdale, John F.
    Kanter, Julie
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Francis J., Jr.
    Shi, Weiliang
    Ribeil, Jean-Antoine
    Asmal, Mohammed
    Thompson, Alexis A.
    Walters, Mark C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [6] Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy
    Magrin, Elisa
    Semeraro, Michaela
    Magnani, Alessandra
    Puy, Herve
    Miccio, Annarita
    Hebert, Nicolas
    Diana, Jean-Sebastien
    Lefrere, Francois
    Suarez, Felipe
    Hermine, Olivier
    Brousse, Valentine
    Poirot, Catherine
    Bourget, Philippe
    El Nemer, Wassim
    Guichard, Isabelle
    Moshous, Despina
    Neven, Benedicte
    Monpoux, Fabrice
    Poiree, Marilyne
    Bartolucci, Pablo
    Meritet, Jean-Francois
    Grevent, David
    Lefebvre, Thibaud
    Asmal, Mohammed
    Whitney, Erin
    Gayron, Marisa
    Huang, Wenmei
    Funck-Brentano, Isabelle
    de Montalembert, Mariane
    Joseph, Laure
    Ribeil, Jean-Antoine
    Cavazzana, Marina
    BLOOD, 2019, 134
  • [7] Current Results of Lentiglobin Gene Therapy in Patients with Severe Sickle Cell Disease Treated Under a Refined Protocol in the Phase 1 Hgb-206 Study
    Tisdale, John F.
    Kanter, Julie
    Mapara, Markus Y.
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Francis J., Jr.
    Shi, Weiliang
    Ribeil, Jean-Antoine
    Asmal, Mohammed
    Thompson, Alexis A.
    Walters, Mark C.
    BLOOD, 2018, 132
  • [8] LENTIGLOBIN GENE THERAPY FOR PATIENTS WITH SICKLE CELL DISEASE: UPDATED RESULTS FROM STUDY HGB-206
    Thompson, Alexis
    Krishnamurti, Lakshmanan
    Mapara, Markus
    Kwiatkowski, Janet
    Tisdale, John
    Schmidt, Manfred
    Miller, Alexandra
    Pierciey, Francis, Jr.
    Huang, Wenmei
    Ribeil, Jean-Antoine
    Kanter, Julie
    Walters, Mark
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S32 - S32
  • [9] Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy (GT): Updated Results in Group C Patients from the Phase 1/2 HGB-206 Study
    Mapara, Markus Y.
    Tisdale, John F.
    Kanter, Julie
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Francis J., Jr.
    Bonner, Melissa
    Huang, Wenmei
    Ribeil, Jean-Antoine
    Thompson, Alexis A.
    Walters, Mark C.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 78 - 79
  • [10] Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy (GT): Updated Results in Group C Patients from the Phase 1/2 Hgb-206 Study
    Walters, Mark C.
    Kanter, Julie
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Mapara, Markus Y.
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Jr. Francis J.
    Bonner, Melissa
    Huang, Wenmei
    Ribeil, Jean-Antoine
    Thompson, Alexis A.
    Tisdale, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S1 - S2
12345